Correlation Between Lyra Therapeutics and Cocrystal Pharma

Can any of the company-specific risk be diversified away by investing in both Lyra Therapeutics and Cocrystal Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lyra Therapeutics and Cocrystal Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Lyra Therapeutics and Cocrystal Pharma, you can compare the effects of market volatilities on Lyra Therapeutics and Cocrystal Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lyra Therapeutics with a short position of Cocrystal Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lyra Therapeutics and Cocrystal Pharma.

Diversification Opportunities for Lyra Therapeutics and Cocrystal Pharma

-0.71

Correlation Coefficient

Lyra Therapeutics  Cocrystal Pharma

Pay attention - limited upside

The 3 months correlation between Lyra and Cocrystal is -0.71. Overlapping area represents the amount of risk that can be diversified away by holding Lyra Therapeutics and Cocrystal Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cocrystal Pharma and Lyra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lyra Therapeutics are associated (or correlated) with Cocrystal Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cocrystal Pharma has no effect on the direction of Lyra Therapeutics i.e., Lyra Therapeutics and Cocrystal Pharma go up and down completely randomly.

Pair Corralation between Lyra Therapeutics and Cocrystal Pharma

Given the investment horizon of 90 days Lyra Therapeutics is expected to under-perform the Cocrystal Pharma. But the stock apears to be less risky and, when comparing its historical volatility, Lyra Therapeutics is 1.14 times less risky than Cocrystal Pharma. The stock trades about -0.07 of its potential returns per unit of risk. The Cocrystal Pharma is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest  217.00  in Cocrystal Pharma on September 25, 2024 and sell it today you would earn a total of  35.00  from holding Cocrystal Pharma or generate 16.13% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Lyra Therapeutics  vs.  Cocrystal Pharma

Lyra Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Lyra Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Cocrystal Pharma

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Cocrystal Pharma are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. Even with relatively unsteady fundamental indicators, Cocrystal Pharma reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Lyra Therapeutics and Cocrystal Pharma

The main advantage of trading using opposite Lyra Therapeutics and Cocrystal Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lyra Therapeutics position performs unexpectedly, Cocrystal Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cocrystal Pharma will offset losses from the drop in Cocrystal Pharma's long position.

The idea behind Lyra Therapeutics and Cocrystal Pharma pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.